Discounted Cash Flow
Legend Biotech Corp. ADR
—
—
Average annual growth rates
| Metric | 10-Year | 5-Year | 3-Year |
|---|---|---|---|
| Sales | — | — | — |
| Free Cash Flow | — | — | — |
| Average (FCF & NI) | — | — | — |
| Net Income | — | — | — |
| Dividends | — | — | — |
Endpoint CAGR (better for long term trend)
| Metric | 10-Year | 5-Year | 3-Year |
|---|---|---|---|
| Sales | — | — | — |
| Free Cash Flow | — | — | — |
| Average (FCF & NI) | — | — | — |
| Net Income | — | — | — |
Projected growth rate
—
—
%
%
Historical inputs (10 fiscal years)
| YEAR | Sales | Net Income | Free Cash Flow | Net Margin | EPS (diluted) |
|---|---|---|---|---|---|
| 2017 | — | — | — | — | — |
| 2018 | $49.1m | $-2.8m | $-2.8m | -5.7% | $-0.01 |
| 2019 | $57.3m (16.5%) | $-133.0m (-4676.3%) | $-87.1m (-3027.4%) | -232.2% (-3998.1%) | $-0.66 (-6500.0%) |
| 2020 | $75.7m (32.2%) | $-303.5m (-128.2%) | $-231.3m (-165.6%) | -401.0% (-72.7%) | $-1.28 (-93.9%) |
| 2021 | $68.8m (-9.1%) | $-403.6m (-33.0%) | $-209.5m (9.4%) | -586.4% (-46.2%) | $-1.43 (-11.7%) |
| 2022 | $117.0m (70.0%) | $-446.3m (-10.6%) | $-211.5m (-0.9%) | -381.5% (34.9%) | $-1.40 (2.1%) |
| 2023 | $285.1m (143.7%) | $-518.3m (-16.1%) | $-404.0m (-91.0%) | -181.8% (52.4%) | $-1.47 (-5.0%) |
| 2024 | $627.2m (120.0%) | $-177.0m (65.8%) | $-154.7m (61.7%) | -28.2% (84.5%) | $-0.48 (67.3%) |
| 2025 | $1.0b (64.0%) | $-296.8m (-67.7%) | $-109.6m (29.2%) | -28.8% (-2.2%) | $-0.81 (-68.8%) |
Base FCF: — (latest fiscal year)
Discount rate: % —
Terminal growth: —
Projection period: — years
Alt A decline yrs:
Alt B total yrs:
Projected cash flows
| Year | Projected cash flow | Discount Factor | Present Value |
|---|
PV of projected FCF: —
Terminal FCF: —
Terminal value: —
PV of terminal value: —
Enterprise value (DCF): —
Current price: —
—Alternative DCF Models
| Model | Fair Value | Upside | PV(FCFs) | PV(Terminal) | Total Years |
|---|---|---|---|---|---|
| Standard (10yr→TV) | — | — | — | — | 10 + TV |
| Alt A (Gradual Decline) | — | — | — | — | — |
| Alt B (30yr Hard Stop) | — | — | — | N/A | — |
This is a simplified DCF model for illustration. It uses reported free cash flow, a single growth assumption, fixed WACC, and a Gordon Growth terminal value. It is not investment advice.